DIANT Pharma

Storrs Mansfield, United States

DIANT Pharma develops continuous processing technology for nanoparticle drug products and vaccines.

$292K raised

May 2025

Equity Crowdfunding

Top Investors

National Science Foundation

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has DIANT Pharma raised?

DIANT Pharma has raised $292K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in May 2025.

Who are DIANT Pharma's investors?

DIANT Pharma's investors include National Science Foundation.

Where is DIANT Pharma headquartered?

DIANT Pharma is headquartered in Storrs Mansfield, United States.

What does DIANT Pharma do?

DIANT Pharma develops continuous processing technology for nanoparticle drug products and vaccines.

What stage is DIANT Pharma at?

DIANT Pharma is at the Equity Crowdfunding stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 1, 2025.

MLA

"DIANT Pharma — Funding & Investors." VCBacked, May 1, 2025, https://www.vcbacked.co/company/diant-pharma. Accessed July 1, 2026.

APA

VCBacked. (2025). DIANT Pharma — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/diant-pharma

Wikipedia (cite web)

{{cite web |title=DIANT Pharma — Funding & Investors |url=https://www.vcbacked.co/company/diant-pharma |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 1, 2025.